Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Super Micro Computer Inc (SMCI) Price & Performance

Enveric Biosciences IncTrade
Super Micro Computer IncTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Super Micro Computer Inc — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while Super Micro Computer Inc trades at $43.32 (market cap $28.10B). The key difference: Super Micro Computer Inc is far larger — about 4132.4× Enveric Biosciences Inc's market cap, and Super Micro Computer Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Super Micro Computer Inc for 19 Days on average.

ENVBSMCI
Market Cap
$6.80M$28.10B
Volume
64,86738,581,805
Sector
HealthTechnology
52-Week High
$10.80$57.98
52-Week Low
$1.27$20.53
Typical Hold Time
14 Days19 Days
Enterprise Value
-$1.49M$33.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.

The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.

Super Micro Computer Inc

Super Micro Computer (SMCI) trades at $44.95, up 3.43% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $22B to $39.1B projected for 2026, net income margin expansion to 5.7%, and consistent earnings beats. Recent AI server demand and NVIDIA Vera Rubin shipments highlight business momentum, though RSI levels suggest potential near-term overbought conditions.

SMCI presents a compelling growth story with AI infrastructure expansion driving financial performance, trading at attractive valuations (P/E 13.12, P/S 0.76). However, investors face risks including margin pressure, competitive AI server market dynamics, and ongoing regulatory investigation. Analyst consensus remains mixed with 36% buy ratings despite price target below current levels at $42.33.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENVB

No sentiment data available yet.

SMCI
37% Buy63% Sell
Avg holding period · 19 Days

Top news

Latest headlines on both assets

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB →

About Super Micro Computer Inc

Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.

Read more on SMCI →